StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for AnaptysBio

AnaptysBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More AnaptysBio figures

See a number that looks wrong?